Roivant Sciences Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 35,492 shares at $7.71 ($278K) on 2019-06-03, disclosed to the SEC on 2019-06-03.
Scheduled purchase ($278k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 6,951 | $55K | 19.9% |
| 2 | $7.97 | 6,951 | $55K | 19.9% |
| 3 | $8.91 | 300 | $3K | 1.0% |
| 4 | $8.91 | 300 | $3K | 1.0% |
| 5 | $7.70 | 5,071 | $39K | 14.0% |
| 6 | $7.70 | 5,071 |
| $39K |
| 14.1% |
| 7 | $7.71 | 5,424 | $42K | 15.0% |
| 8 | $7.71 | 5,424 | $42K | 15.0% |
| Total | $7.83 avg | 35,492 | $278K | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |